| Old Articles: <Older 8901-8910 Newer> |
|---|
 |
Pharmaceutical Executive
August 1, 2014
Turbeville et al. |
Google Glass -- A User's Guide in Healthcare Three medical affairs experts review the capabilities of Google's latest technology for delivering information to healthcare professionals in the field.   |
Pharmaceutical Executive
August 1, 2014
Jill Wechsler |
Social Media Struggles Continue Tweeting limited, corrections okay, says FDA, as industry, regulators wrestle with the digital world. |
Pharmaceutical Executive
August 1, 2014
William Looney |
A Window on the Industry: The Emerging Pharma Leaders 2014 Pharm Exec's 2014 roster of emerging pharma leaders serves as a window on work in an industry that relies on human capital as the coinage of success. |
Chemistry World
August 6, 2014
Hepeng Jia |
GSK's China troubles continue The company faces official prosecution over accusations of bribery and corruption, litigation from fired employees and an upcoming trial of private investigators employed to look into a blackmail attempt. |
Chemistry World
August 5, 2014
Dinsa Sachan |
Price caps provoke lawsuits from Indian pharma industry The Indian pharma industry is engaged in a pitched battle with the drug price regulator that recently brought certain drugs under price control. |
Information Today
August 5, 2014 |
Wellcome Library and Jisc Will Digitize Historic Medical Books The Wellcome Library, part of the Wellcome Trust, and Jisc partnered with nine institutions, including six universities, for a 2-year digitization project encompassing 19th-century medical books and pamphlets. |
Chemistry World
August 1, 2014
Sarah Houlton |
Amgen to shed 2400-2900 jobs Most of the job losses will be in the US, predominantly at the former Immunex research facility in Seattle and two biologics manufacturing sites in Colorado. |
Chemistry World
July 31, 2014
Phillip Broadwith |
AstraZeneca stocks respiratory and cancer pipelines AstraZeneca has agreed to buy Spanish firm Almirall's respiratory drug assets for $875 million up front, plus up to $1.2 billion in performance milestone payments. |
Chemistry World
July 28, 2014
Andy Extance |
Takeover battle pushes Allergan to cut R&D jobs Despite a quarterly sales increase it describes as its strongest ever, Botox maker Allergan is laying off 1500 staff as it seeks to fend off a hostile takeover. |
Chemistry World
July 28, 2014
Phillip Broadwith |
Reckitt Benckiser to spin out US pharma arm Consumer health firm Reckitt -- Benckiser plans to spin off its US pharmaceutical division, whose primary product is heroin-substitute Suboxone. |
| <Older 8901-8910 Newer> Return to current articles. |
